Education
About Us
Working with TipRanks
Follow Us
Sarepta Therapeutics (SRPT)
NASDAQ:SRPT
Earnings Data
Report Date
Mar 03, 2026After Close (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
-1.39Last Year’s EPS
1.5Same Quarter Last Year
Based on 23 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The earnings call presented a balanced view, with significant achievements in revenue and study completions, alongside challenges such as the ESSENCE trial missing statistical significance and disruptions from paused shipments.Company Guidance
Solid Net Product Revenue
Sarepta posted solid net product revenue of $370 million for the quarter, despite disruptions.
Successful Completion of Confirmatory Studies
The confirmatory studies for ultra-rare disease CMOs, VYONDYS and AMONDYS, were completed. The studies showed a clinically favorable trend, although they missed statistical significance.
Real-World Evidence Supports PMOs
Over 1,800 patients worldwide have been treated with exon-skipping therapies, showing benefits such as delayed loss of ambulation and preserved pulmonary function.
ELEVIDYS Product Revenue Contribution
ELEVIDYS contributed $131 million in net product revenue for the quarter.
Strong Demand for PMO Franchise
The PMO franchise delivered strong demand performance, contributing $239 million to the quarter's revenue.
Financial Restructuring and Liquidity Improvement
Sarepta enhanced its liquidity and improved its balance sheet by monetizing strategic investments and completing a debt exchange.
SRPT Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
SRPT Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 03, 2025 | $24.45 | $16.20 | -33.74% |
Aug 06, 2025 | $16.26 | $17.96 | +10.46% |
May 06, 2025 | $46.75 | $36.72 | -21.45% |
Feb 26, 2025 | $106.86 | $103.06 | -3.56% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Sarepta Therapeutics (SRPT) report earnings?
Sarepta Therapeutics (SRPT) is schdueled to report earning on Mar 03, 2026, After Close (Confirmed).
What is Sarepta Therapeutics (SRPT) earnings time?
Sarepta Therapeutics (SRPT) earnings time is at Mar 03, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is SRPT EPS forecast?
SRPT EPS forecast for the fiscal quarter 2025 (Q4) is -1.39.
